Kim M, Yang S, Kim BR, Youn SW, et al. Epidermal Hyperproliferation With Less Prominent Dermal Inflammation Is the Unique Histopathological Feature of the Refractory Lesions in Psoriasis Treated With Ustekinumab. Am J Dermatopathol 2021 Nov 2. pii: 00000372-900000000-97647.
PMID: 34726183